SCHEMBL4858827

SCHEMBL4858827

NCC1COc2ccc([N+](=O)[O-])cc2O1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CHRNB4 P30926 4/20 0.51
CHRNA3 P32297 4/20 0.51
MEN1 O00255 5/20 0.48
KMT2A Q03164 5/20 0.48
MAPT P10636 4/20 0.41
PKM P14618 1/20 0.41
CA2 P00918 2/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
LOXL2 Q9Y4K0 1/20 0.40
CRHBP P24387 1/20 0.40
CRHR2 Q13324 1/20 0.40
HTR6 P50406 1/20 0.38
ALDH1A1 P00352 2/20 0.38
CYP3A4 P08684 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21213913 1.00 CHRNB4 (0.51) CHRNB4CHRNA3MEN1KMT2AMAPT
SCHEMBL3033668 0.86 CHRNB4 (0.51) CHRNB4CHRNA3MEN1KMT2AMAPT
SCHEMBL3029057 0.86 CHRNB4 (0.51) CHRNB4CHRNA3MEN1KMT2AMAPT
SCHEMBL5845776 0.86 CHRNB4 (0.51) CHRNB4CHRNA3MEN1KMT2AMAPT
SCHEMBL6070253 0.86 CHRNB4 (0.51) CHRNB4CHRNA3MEN1KMT2AMAPT
SCHEMBL4787850 0.84 MEN1 (0.44) CHRNB4CHRNA3MEN1KMT2AMAPT
SCHEMBL3034976 0.83 CHRNB4 (0.49) CHRNB4CHRNA3MEN1KMT2AMAPT
SCHEMBL5582827 0.82 CHRNB4 (0.51) CHRNB4CHRNA3MEN1KMT2AMAPT
SCHEMBL5937089 0.82 CHRNB4 (0.51) CHRNB4CHRNA3MEN1KMT2AMAPT
SCHEMBL443131 0.81 CA2 (0.67) CHRNB4CHRNA3MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008118935-A1 COMPOUNDS AND PROCESSES FOR PREPARING SUBSTITUTED AMINOMETHYL-2,3,8,9-TETRAHYDRO-7H-1,4-DIOXINO[2,3-E]INDOL-8-ONES NEUROGEN CORPORATION (US) 2008-10-02 WO disclosed